MA17.08 Safety and Efficacy of Tifcemalimab Combined with Toripalimab in Refractory Extensive Stage Small Cell Lung Cancer

• DOI: 10.1016/j.jtho.2024.09.226
• Publication Date: 2024-10-16T02:38:57Z
• Authors: Y. Cheng; J. Wang; Y. Yu; Q. Wang; R. Yang; D. Lv; B. Xia; T. Yi; C. Li; X. Wang; W. Zhang; L. Han; X. Liu; M. Su; M. Shen; J. Xu; J. Wang; L. Zhang
• Keywords: Refractory (planetary science)